SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced its participation in several upcoming investor conferences, including the Credit Suisse 30th Annual Healthcare Conference on November 11, the Piper Sandler 33rd Annual Healthcare Conference starting November 22, and the Evercore ISI HealthCONx Conference on November 30. Investors can access live and archived presentations through the company's Investors section on their website. SOPHiA GENETICS focuses on data-driven medicine, utilizing its cloud-based SOPHiA DDM™ Platform in over 780 institutions worldwide.

BOSTON and LAUSANNE, Switzerland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences:

• Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11^th at 2:40pm ET / 8:40pm CET
  
  
• Piper Sandler 33^rd Annual Healthcare Conference; Presentation available on demand beginning November 22^nd at 10:00am ET / 4:00pm CET
  
  
• Evercore ISI HealthCONx Conference; Fireside Chat on Tuesday, November 30^th at 8:00am ET / 2:00pm CET
  

Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at ir.sophiagenetics.com.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Media Contact:
Eliza Bamonti
ebamonti@sophiagenetics.com

Investor Contact:
ir@sophiagenetics.com

FAQ

What conferences will SOPHiA GENETICS participate in November 2021?

SOPHiA GENETICS will participate in three conferences: Credit Suisse 30th Annual Healthcare Conference on November 11, Piper Sandler 33rd Annual Healthcare Conference beginning November 22, and Evercore ISI HealthCONx Conference on November 30.

How can I access presentations from SOPHiA GENETICS' conferences?

Presentations can be accessed live and in archive on the 'Investors' section of SOPHiA GENETICS' website.

What is the focus of SOPHiA GENETICS' business?

SOPHiA GENETICS is dedicated to establishing data-driven medicine as standard practice in healthcare and life sciences research.

What is the SOPHiA DDM™ Platform?

The SOPHiA DDM™ Platform is a cloud-based SaaS solution that analyzes complex multimodal data sets and generates insights.

How many institutions use SOPHiA GENETICS' solutions?

More than 780 hospitals, laboratories, and biopharma institutions worldwide use SOPHiA GENETICS' solutions.